JVRS-100

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameJVRS-100
Drug Alias NameCLDC adjuvant (Colby)JuvImmune vaccine adjuvant (Juvaris)JVRS-100
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJuvaris Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColby Pharmaceutical Company
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A